[Contraception with levonorgestrel (Norplant) subcutaneous implants. African experience in Burkina Faso].
The subcutaneous implants from the levonorgestrel (Norplant) has been introduced in Burkina Faso in September 1992 within the context of a project assisted by a non-governmental organization (the Population Council). The aim was to reinforce the family planning programme in Burkina Faso by increasing the number of family planning methods available for the clients. 4 years after its introduction, we propose to make a report of our experience in terms of the contraception through subcutaneous implants in order to better set up an IEC campaign on this method. Within 4 years, 1,660 users benefitted from that contraceptive method. They were housewives in 65% of the cases. The age-group of 30-34 years old most used this method with 28.6%. Multipares most benefitted from this method with 64.3%. In 72% of the cases, the insertion was made during the premenstrual period. On the whole, 247 withdrawals have been made before the fourth years for various reasons. Among those reasons are cycle disorders (60 withdrawals), medical reasons (53 withdrawals), personal conveniences (47 withdrawals), weight gaining (14 withdrawals), failures (2 withdrawals). Regarding the side effects, they were mainly represented by the menstrual cycle disorders such as amenorrhoea, spotting, hypermenorrhoea in 51% of the cases. A good information and sensitization campaign should reduce the number of implants withdrawals before the fourth year of use. Moreover, a perfect knowledge of contraindications is indispensable before any prescription.
Koné
B
B
Département de Gynécologie et d'Obstétrique, Faculté des Sciences de la Santé, Université de Ouagadougou, Burkina Faso.
Lankoandé
J
J
Ouédraogo
C M
CM
Ouédraogo
A
A
Bonané
B
B
Dao
B
B
Sanou
J
J
D000328:Adult; D002050:Burkina Faso; D003271:Contraceptive Agents, Female / Q000009:adverse effects; D004343:Drug Implants; D005193:Family Planning Services / Q000379:methods*; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D016912:Levonorgestrel / Q000009:adverse effects; D010298:Parity
D003271:Contraceptive Agents, Female; D004343:Drug Implants; D016912:Levonorgestrel